Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiographyErdal Cavusoglu
Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
Am J Cardiol 100:1739-43. 2007
..In conclusion, these data demonstrate that low baseline levels of total choline-containing phospholipid are a strong and independent predictor of cardiovascular outcomes (including mortality) in patients with acute coronary syndromes...
- Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203 2098, USA
Arterioscler Thromb Vasc Biol 27:929-35. 2007
..RANTES is a chemokine produced by a variety of cell types including platelets that has been implicated in atherosclerosis...
Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiographyErdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA
Int J Cardiol 141:141-6. 2010
..However, there are no data in other cardiac populations, including patients with acute coronary syndromes (ACS)...
- Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, Bronx Veterans Affairs Medical Center, NY, USA
Am J Med 124:724-30. 2011
..The objective of the present study was to investigate the long-term prognostic significance of baseline IL-10 levels in patients with acute coronary syndrome...
- Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York 11203 2098, USA
Coron Artery Dis 20:112-7. 2009
..However, there are very limited data in patients with acute coronary syndromes (ACS)...
- Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patients referred for coronary angiography
Erdal Cavusoglu
Department of Medicine, State University of New York Health Science Center, Brooklyn, New York, USA
Am J Cardiol 101:1073-8. 2008
..52, 95% confidence interval 1.15 to 2.02, p = 0.0034). In conclusion, baseline plasma adiponectin was an independent predictor of LV systolic dysfunction in a population of patients referred for coronary angiography...
- Relation of baseline serum potassium levels to angiographic findings in patients with known or suspected coronary artery disease
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
Am J Hypertens 22:754-62. 2009
..The objective of this study was to determine the association between plasma potassium levels and angiographically defined coronary artery disease (CAD)...
- Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography
Erdal Cavusoglu
Department of Medicine, Division of Cardiology, SUNY Downstate Medical Center, Brooklyn, NY 11203 2098, United States
Atherosclerosis 207:261-5. 2009
..39, 95% CI 1.18-4.86, p=0.0161 and OR 1.41, 95% CI 1.05-1.89, p=0.0206, respectively). In conclusion, PLTP activity may represent a novel marker of LV systolic dysfunction in patients with known or suspected coronary artery disease...
- Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York 11203 2098, USA
J Am Coll Cardiol 50:1768-76. 2007
..The purpose of this study was to determine the association of the F11 receptor (F11R) with human vascular disease...
- Clopidogrel in the management of ischemic heart disease
Erdal Cavusoglu
Department of Medicine, Bronx VA Medical Center, Bronx, NY 10468, USA
Heart Dis 5:144-52. 2003
..Therefore, despite improved outcomes, further studies are required to determine the optimal duration and dosage regimen of such combination therapy to maximize its risk-benefit ratio...
- The use of clopidogrel in patients with coronary artery disease
Erdal Cavusoglu
Interventional Cardiology SUNY Downstate Medical Center, Brooklyn, New York 11203 2098, USA
Anadolu Kardiyol Derg 4:63-72. 2004
..This article focuses on clopidogrel, an antiplatelet agent belonging to the class of drugs known as the thienopyridines, in the treatment of patients with coronary artery disease...
- Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, United States
Atherosclerosis 210:226-31. 2010
..High baseline plasma levels of ADMA in patients with DM have been shown to predict diabetes related complications. However, there are limited data on the prognostic significance of baseline ADMA levels in patients with established DM...
- Usefulness of the serum complement component C4 as a predictor of stroke in patients with known or suspected coronary artery disease referred for coronary angiography
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
Am J Cardiol 100:164-8. 2007
..In conclusion, in a cohort of men across a spectrum of risk referred for coronary angiography, a single baseline determination of serum complement C4 level is an independent predictor of the future development of stroke...
- Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angiography
Erdal Cavusoglu
Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA
Am J Cardiol 98:1189-93. 2006
....
- Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
Am J Cardiol 99:1364-8. 2007
..34 ng/ml was 88% compared with 74% in those whose values were >20.34 ng/ml (p = 0.0249 by log-rank test). In conclusion, these data demonstrate that baseline MPO levels independently predict MI at 2 years in patients with ACS...
- Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203-2098, USA
Eur Heart J 27:2300-9. 2006
..CONCLUSION: In a cohort of male patients undergoing coronary angiography, a single baseline determination of plasma adiponectin is independently predictive of the subsequent risk of death and MI...
- Bolus-only platelet glycoprotein IIb-IIIa inhibition during percutaneous coronary intervention
Jonathan D Marmur
State University of New York, SUNY Downstate Medical Center, Brooklyn, New York, USA
J Invasive Cardiol 18:521-6. 2006
....
- Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction
Erdal Cavusoglu
Department of Medicine, State University of New York Health Science Center, Brooklyn, NY 11203-2098, USA
Am Heart J 151:1101.e1-8. 2006
..CONCLUSIONS: In a cohort of male patients undergoing coronary angiography, a single baseline determination of plasma TIMP-1 is independently predictive of the subsequent risk of death and MI...
- Long-term mortality after bolus-only administration of abciximab, eptifibatide, or tirofiban during percutaneous coronary intervention
Jonathan D Marmur
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA
Catheter Cardiovasc Interv 73:214-21. 2009
..To evaluate the long-term mortality after bolus-only administration of abciximab, eptifibatide, and tirofiban during percutaneous coronary intervention (PCI)...
- Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, New York, USA
Am J Cardiol 98:580-4. 2006
..0065 by log-rank test). In conclusion, these data demonstrate that baseline anemia is a strong and independent predictor of death or AMI at 2 years in patients with ACS...
- Activated clotting time (ACT)-guided intravenous dalteparin dosing during percutaneous coronary intervention
Jonathan D Marmur
Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, New York, USA
J Invasive Cardiol 20:323-7. 2008
..The activated clotting time (ACT) has been reported to be sensitive to the anticoagulant activity of the low-molecular weight heparin dalteparin following intravenous (IV) administration...
- Impact of body mass index on long-term all-cause mortality after percutaneous coronary intervention in African-Americans
Shyam Poludasu
Cardiology, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA
J Invasive Cardiol 21:20-5. 2009
..Hypothesis. We assessed the hypothesis that BMI is an independent predictor of post-PCI long-term mortality in African-Americans...
- Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans
Spyros Kokolis
S.U.N.Y. Downstate Medical Center, Brooklyn, New York, USA
J Invasive Cardiol 18:304-7. 2006
..There appears to be an inverse relationship between CAD and left ventricular function in patients with a history of heavy alcohol consumption...
- All-cause mortality after drug-eluting stent implantation in African-Americans
Shyam Poludasu
Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, New York 11203 2098, USA
Coron Artery Dis 19:551-7. 2008
..The effect of drug-eluting stents on mortality in African-Americans is unknown...
- Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin
Sunil X Anand
The Zena and Michael A Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA
Am J Cardiol 100:417-24. 2007
..These data suggest that bivalirudin and UFH may confer an anti-inflammatory effect by reducing sCD40L during PCI...
- Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosis
Bani M Azari
Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY 11203 2098, USA
Atherosclerosis 212:197-205. 2010
..Here we report our investigation of the expression of F11R in atherosclerotic arteries of coronary artery disease (CAD) patients, and of the role of F11R in the migration of SMCs involved in atherogenesis...
- Effect of hemoglobin level on long-term all-cause mortality after percutaneous coronary intervention in African-Americans
Shyam Poludasu
Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, USA
Am J Cardiol 103:1078-82. 2009
..6 for group with Hgb > or =11.1 to <12.7 compared with the group with the highest Hgb value). In conclusion, baseline Hgb is a strong and independent predictor of all-cause long-term mortality in African-Americans undergoing PCI...
- High-dose tirofiban administered as bolus-only during percutaneous coronary intervention
Jonathan D Marmur
SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 1257, Brooklyn, NY, 11203 2098, USA
J Invasive Cardiol 20:53-8. 2008
....
- Neutrophil to lymphocyte ratio as a predictor of long-term mortality in African Americans undergoing percutaneous coronary intervention
Shyam Poludasu
Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, New York, USA
Clin Cardiol 32:E6-E10. 2009
..African Americans have been shown to have lower mean neutrophil counts compared to whites. The usefulness of the N/L ratio in predicting long-term mortality in African Americans undergoing PCI is unknown...
- Impact of gender on in-hospital percutaneous coronary interventional outcomes in African-Americans
Shyam Poludasu
Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, New York, USA
J Invasive Cardiol 19:123-8. 2007
..The impact of gender on post-PCI outcomes in African-Americans has not been reported...
- Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial
Jonathan D Marmur
Division of Cardiology, Department of Medicine, State University of New York Health Science Center at Brooklyn, NY 11203-2098, USA
Am Heart J 152:876-81. 2006
..The early protective ischemic effect of abciximab bolus-only observed in the EPIC trial may be relevant in this regard...
- A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory
Jonathan D Marmur
Department of Cardiology, SUNY Health Sciences Center at Brooklyn, 450 Clarkson Avenue, Box 1257, Brooklyn, NY 11203, USA
J Invasive Cardiol 20:449-54. 2008
....
- Avoiding intelligence failures in the cardiac catheterization laboratory: Strategies for the safe and rational use of dalteparin or enoxaparin during percutaneous coronary intervention
Jonathan D Marmur
Department of Medicine, State University of New York Health Science Center at Brooklyn, 11203 2098, USA
J Invasive Cardiol 21:653-64. 2009
....
- Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention
Shyam Poludasu
Division of Cardiology, Department of Medicine, State University of New York, Downstate Medical Center, Brooklyn, NY 11203 2098, USA
Thromb Haemost 102:581-7. 2009
..7, HR for death in patients with high RDW relative to low RDW was 8.6 (CI:2.8-28.6). Higher RDW was a strong and independent predictor of long-term mortality in patients undergoing PCI who were not anaemic at baseline...
- Very late bare-metal stent thrombosis. A case report and review of the literature
Nagarathna Manjappa
Interventional Cardiology Division, SUNY Downstate Medical Center, Brooklyn, New York, USA
J Invasive Cardiol 18:E203-6. 2006
..We report a case of very late thrombosis of a bare-metal stent occurring 717 days after implantation...
- The activated clotting time (ACT) can be used to monitor enoxaparin and dalteparin after intravenous administration
Erdal Cavusoglu
Division of Cardiology, Department of Medicine, the Bronx Veterans Administration Medical Center, Bronx, NY, USA
J Invasive Cardiol 17:416-21. 2005
..These data support an ACT-guided strategy for intravenously administered LMWH during PCI. Additional studies with larger patient populations may be indicated to determine the ideal target ACT for LMWH in PCI...
- Beyond lipid lowering: the anti-hypertensive role of statins
Vineet Chopra
Division of Internal Medicine, Bronx Veterans Affairs Medical Center and the Mount Sinai School of Medicine, Bronx, NY, USA
Cardiovasc Drugs Ther 21:161-9. 2007
....
- Current status of rotational atherectomy
Erdal Cavusoglu
Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA
Catheter Cardiovasc Interv 62:485-98. 2004
..Recommendations are also made for its use in the current interventional era...
- Percutaneous coronary intervention in a patient with congenital factor XI deficiency and acquired inhibitor
Sudhir Mungee
Division of Cardiology, SUNY Downstate Medical Center, Brooklyn, NY 11203 2098, USA
Cardiology 107:69-72. 2007
..Immunosuppressive therapy, plasma exchange and factor VII product transfusions have been used prior to cardiac interventions in few such reported cases...
- Direct thrombin inhibitor use during percutaneous coronary intervention
Spyros Kokolis
State University of New York Health Science Center at Brooklyn, Brooklyn, New York 11203, USA
J Cardiovasc Pharmacol 45:270-9. 2005
..We review the pharmacological properties of these newer antithrombotic agents and evaluate the clinical data demonstrating their use in patients undergoing PCI...
- Catheter-induced spasm of the left main coronary artery due to anatomic "kinking" in its course
Umesh S Lingegowda
Division of Cardiology, Department of Medicine, SUNY, Downstate Medical Center, Box 1199, 450 Clarkson Avenue, Brooklyn, NY, 11203, USA
J Invasive Cardiol 17:192-4. 2005
- Contrast-associated nephropathy
Vikas R Soma
Department of Medicine, Bronx VA Medical Center, Bronx, New York, USA
Heart Dis 4:372-9. 2002
..The growing use of these new agents, such as acetylcysteine, endothelin blockers, and most recently fenoldopam, has increased the options available for the prevention of CaN...
- The use of the glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary intervention
Jonathan D Marmur
Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA
J Interv Cardiol 15:71-84. 2002
..Finally, evidence indicates that the majority of patients with acute coronary syndromes without ST segment elevation who are scheduled to undergo PCI should be pretreated with a GPIIb/IIIa receptor antagonist...
- Twiddler's syndrome: an interesting cause of pacemaker failure
Ricardo Castillo
Section of Cardiology, Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA
Cardiology 105:119-21. 2006
..This report underscores the importance of dementia as a risk factor for twiddler's syndrome...
- Anticoagulation strategies for patients undergoing percutaneous coronary intervention: unfractionated heparin, low-molecular-weight heparins, and direct thrombin inhibitors
Spyros Kokolis
State University of New York, Health Science Center at Brooklyn, 11203, USA
Prog Cardiovasc Dis 46:506-23. 2004
..This paper reviews the pharmacologic properties of these newer antithrombotic agents and evaluates the clinical data demonstrating their use in patients undergoing PCI...
